Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 29 citing articles:

NK cell-based tumor immunotherapy
Hao Zhang, Yang Li, Tingting Wang, et al.
Bioactive Materials (2023) Vol. 31, pp. 63-86
Open Access | Times Cited: 46
Antigen Self-Presented Personalized Nanovaccines Boost the Immunotherapy of Highly Invasive and Metastatic Tumors
Tingting Wang, Mengxiao Han, Yaobao Han, et al.
ACS Nano (2024) Vol. 18, Iss. 8, pp. 6333-6347
Closed Access | Times Cited: 18
Brain-Targeting Drug Delivery Systems: The State Of The Art In Treatment Of Glioblastoma
Bo Sun, Rong Li, Ning Ji, et al.
Materials Today Bio (2025) Vol. 30, pp. 101443-101443
Open Access | Times Cited: 3
Enhancing cancer immunotherapy: Nanotechnology-mediated immunotherapy overcoming immunosuppression
Yunna Chen, Qianqian Zhou, Zongfang Jia, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3834-3854
Open Access | Times Cited: 16
Recent Advances in Biomimetic Strategies for the Immunotherapy of Glioblastoma
Haoyu You, Shuo Geng, Shangkuo Li, et al.
Biomaterials (2024) Vol. 311, pp. 122694-122694
Closed Access | Times Cited: 10
Copper-Based Biomaterials for Anti-Tumor Therapy: Recent Advances and Perspectives
Shufang Zhang, Shuping Peng
Acta Biomaterialia (2025)
Closed Access | Times Cited: 1
Versatile Copper-Chalcogenide-Based Nanoparticles for the Treatment of Brain Diseases
Shuyang Xie, Hualong Liu, Ke Yang, et al.
Nano Biomedicine and Engineering (2025)
Open Access | Times Cited: 1
Ameliorating Mitochondrial Dysfunction for the Therapy of Parkinson's Disease
Qing Yin Zheng, Hanghang Liu, Yifan Gao, et al.
Small (2024) Vol. 20, Iss. 29
Closed Access | Times Cited: 8
Cell Membrane Camouflaged Biomimetic Nanoparticles as a Versatile Platform for Brain Diseases Treatment
Shiyu Wang, Longfei Yang, Wenya He, et al.
Small Methods (2024)
Closed Access | Times Cited: 8
In Situ Nitric Oxide Gas Nanogenerator Reprograms Glioma Immunosuppressive Microenvironment
Yang Liu, Lin Cui, Xiao Wang, et al.
Advanced Science (2023) Vol. 10, Iss. 18
Open Access | Times Cited: 12
Boost Infiltration and Activity of T Cells via Inhibiting Ecto-5′-nucleotidase (CD73) Immune Checkpoint to Enhance Glioblastoma Immunotherapy
Hao Zhang, Yang Li, Mengxiao Han, et al.
ACS Nano (2024) Vol. 18, Iss. 34, pp. 23001-23013
Closed Access | Times Cited: 4
Immune response recalibration using immune therapy and biomimetic nano-therapy against high-grade gliomas and brain metastases
Puja Sandhbor, Geofrey John, Sakshi Bhat, et al.
Asian Journal of Pharmaceutical Sciences (2025), pp. 101021-101021
Open Access
Recent advances in biomimetic nanodelivery systems for cancer Immunotherapy
Jiawei Yang, Xueqi Li, Tongyu Li, et al.
Materials Today Bio (2025), pp. 101726-101726
Open Access
Glioblastoma Cell Lysate and Adjuvant Nanovaccines via Strategic Vaccination Completely Regress Established Murine Tumors
Songsong Zhao, Yun Qu, Zhiwei Sun, et al.
Advanced Healthcare Materials (2025)
Closed Access
Cancer Cell Membrane‐Based Materials for Biomedical Applications
Yongping Lu, Linming Fan, Jun Wang, et al.
Small (2023) Vol. 20, Iss. 7
Open Access | Times Cited: 10
Role of T Lymphocytes in Glioma Immune Microenvironment: Two Sides of a Coin
Lubna Noor, Arun Upadhyay, Vibhuti Joshi
Biology (2024) Vol. 13, Iss. 10, pp. 846-846
Open Access | Times Cited: 3
Nano-Based Strategies Aiming at Tumor Microenvironment for Improved Cancer Therapy
Tianhui Liu, Changshun Lu, Xue Jiang, et al.
Molecular Pharmaceutics (2025)
Closed Access
The Role of TIM-3 in Glioblastoma Progression
Farah Ahmady, Amit Sharma, Adrian Achuthan, et al.
Cells (2025) Vol. 14, Iss. 5, pp. 346-346
Open Access
Biomimetic Hybrid PROTAC Nanovesicles Block Multiple DNA Repair Pathways to Overcome Temozolomide Resistance Against Orthotopic Glioblastoma
Qing Xu, Xing Hu, Ihsan Ullah, et al.
Advanced Materials (2025)
Closed Access
Boosting the therapy of glutamine-addiction glioblastoma by combining glutamine metabolism therapy with photo-enhanced chemodynamic therapy
Ling Wang, Yaobao Han, Zhengpeng Gu, et al.
Biomaterials Science (2023) Vol. 11, Iss. 18, pp. 6252-6266
Closed Access | Times Cited: 8
Nanomaterial-Based Strategies for Attenuating T-Cell-Mediated Immunodepression in Stroke Patients: Advancing Research Perspectives
Yan Wang, Cuiying Liu, Yanhong Ren, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 5793-5812
Open Access | Times Cited: 3
Cancer Cell Membrane-Coated siRNA-Decorated Au/MnO2 Nanosensitizers for Synergistically Enhanced Radio-Immunotherapy of Breast Cancer
Diyu Wang, Subin Lin, Tuanwei Li, et al.
Materials Today Bio (2024) Vol. 29, pp. 101275-101275
Open Access | Times Cited: 3
Autophagy machinery in glioblastoma: The prospect of cell death crosstalk and drug resistance with bioinformatics analysis
Yi Qin, Shengjun Xiong, Jun Ren, et al.
Cancer Letters (2023) Vol. 580, pp. 216482-216482
Closed Access | Times Cited: 8
Inhibition of TNBC Cell Growth by Paroxetine: Induction of Apoptosis and Blockage of Autophagy Flux
Qianrui Huang, Meng‐Ling Wu, Yamin Pu, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 885-885
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top